Remote Assessment: MRI Plus Primary-Cancer Information Together
In a brain metastasis the decision depends not only on the brain MRI but also on the type, stage and molecular features of the primary cancer. For this reason, in an international assessment we ask for both sets of information together: you can obtain an online preliminary assessment by sharing your brain MRI and the reports/pathology-molecular results of your primary cancer via WhatsApp. In this opinion, whether there is a single or multiple metastases, whether local treatment (surgery/Gamma Knife) comes to the fore, and whether traveling to Turkey is meaningful for your situation are discussed honestly.
What Is a Brain Metastasis?
Brain metastases are secondary tumors that form when a primary cancer elsewhere in the body spreads to the brain through the bloodstream. They most often arise from lung, breast and melanoma; less frequently, kidney and colorectal cancers can also spread. They are usually located in the cerebral hemispheres at the gray-white matter junction, and a substantial proportion of cases are multiple. As advances in cancer treatment allow patients to live longer, the incidence of this picture has risen, but its management has also steadily improved. Contrast-enhanced brain MRI is the most sensitive diagnostic method; if the primary cancer is unknown, whole-body staging (PET-CT) is needed—this can be done in your home country and the results shared remotely.
Single or Multiple? How the Decision Is Made
Treatment is planned by a team in which medical oncology, radiation oncology and neurosurgery work together. The first step is usually a steroid (dexamethasone) to reduce edema. For a limited number of metastases, local treatments come to the fore: surgery for a large, symptomatic lesion, and stereotactic radiosurgery (Gamma Knife, CyberKnife) for small-to-moderate or a few lesions. For multiple metastases, whole-brain radiotherapy may be considered alongside Gamma Knife; hippocampal-sparing techniques can reduce cognitive side effects. Systemic treatment (chemotherapy, targeted agents, immunotherapy) is chosen by the molecular profile of the primary cancer and plays an increasingly important role. For an international patient, which part of this combination is delivered in Turkey and which in the home country is planned from the outset.
When Does Surgery Come to the Fore, and the Turkey Journey
Surgical resection comes to the fore especially for a single, large, symptomatic or life-threateningly compressing metastasis; it both removes the mass and provides a tissue diagnosis, and it contributes to diagnosis when the primary cancer is unknown. A solitary, reachable metastasis accompanying a controlled primary disease is a suitable candidate for surgery. If surgery is found appropriate after the remote opinion, the date and estimated length of stay are planned before your arrival; in Turkey the operation is performed while preserving function with neuronavigation and functional mapping, and radiosurgery to the tumor bed is often added. At discharge the procedure performed, the pathology and the recommended next steps are provided in writing.
Prognosis, Realistic Expectations and Multilingual Communication
The course in patients with brain metastases varies widely. Long-term control may be achievable with modern treatments in patients with a single metastasis, good performance status and a targetable molecular feature, whereas prognosis is more limited in widespread disease. Tools such as DS-GPA are used to estimate prognosis; outcomes have improved markedly in recent years for cases that respond to targeted therapy and immunotherapy. For a patient coming from across a border, the most important point is that these expectations and the multi-layered treatment plan are clearly understood in their own language. We make no guaranteed promises; expectations are shared honestly after your images and primary-cancer information are assessed.